Chengdu Easton (China) Market Value

688513 Stock   32.73  0.22  0.67%   
Chengdu Easton's market value is the price at which a share of Chengdu Easton trades on a public exchange. It measures the collective expectations of Chengdu Easton Biopharmaceuticals investors about its performance. Chengdu Easton is trading at 32.73 as of the 28th of November 2024, a 0.67 percent decrease since the beginning of the trading day. The stock's open price was 32.95.
With this module, you can estimate the performance of a buy and hold strategy of Chengdu Easton Biopharmaceuticals and determine expected loss or profit from investing in Chengdu Easton over a given investment horizon. Check out Chengdu Easton Correlation, Chengdu Easton Volatility and Chengdu Easton Alpha and Beta module to complement your research on Chengdu Easton.
Symbol

Please note, there is a significant difference between Chengdu Easton's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chengdu Easton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chengdu Easton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Chengdu Easton 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Chengdu Easton's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Chengdu Easton.
0.00
10/29/2024
No Change 0.00  0.0 
In 31 days
11/28/2024
0.00
If you would invest  0.00  in Chengdu Easton on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Chengdu Easton Biopharmaceuticals or generate 0.0% return on investment in Chengdu Easton over 30 days. Chengdu Easton is related to or competes with HaiXin Foods, Gan Yuan, Shanghai Jinfeng, Tonghua Grape, Shanghai Ziyan, Qingdao Foods, and Hangzhou Pinming. Chengdu Easton is entity of China. It is traded as Stock on SHG exchange. More

Chengdu Easton Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Chengdu Easton's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Chengdu Easton Biopharmaceuticals upside and downside potential and time the market with a certain degree of confidence.

Chengdu Easton Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Chengdu Easton's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Chengdu Easton's standard deviation. In reality, there are many statistical measures that can use Chengdu Easton historical prices to predict the future Chengdu Easton's volatility.
Hype
Prediction
LowEstimatedHigh
29.8032.7135.62
Details
Intrinsic
Valuation
LowRealHigh
26.4929.4036.00
Details

Chengdu Easton Bioph Backtested Returns

Chengdu Easton Bioph secures Sharpe Ratio (or Efficiency) of -0.0417, which signifies that the company had a -0.0417% return per unit of standard deviation over the last 3 months. Chengdu Easton Biopharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Chengdu Easton's risk adjusted performance of 0.007, and Mean Deviation of 1.97 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.0786, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Chengdu Easton are expected to decrease at a much lower rate. During the bear market, Chengdu Easton is likely to outperform the market. At this point, Chengdu Easton Bioph has a negative expected return of -0.12%. Please make sure to confirm Chengdu Easton's market risk adjusted performance, coefficient of variation, information ratio, as well as the relationship between the mean deviation and standard deviation , to decide if Chengdu Easton Bioph performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.75  

Almost perfect reverse predictability

Chengdu Easton Biopharmaceuticals has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Chengdu Easton time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Chengdu Easton Bioph price movement. The serial correlation of -0.75 indicates that around 75.0% of current Chengdu Easton price fluctuation can be explain by its past prices.
Correlation Coefficient-0.75
Spearman Rank Test-0.82
Residual Average0.0
Price Variance1.28

Chengdu Easton Bioph lagged returns against current returns

Autocorrelation, which is Chengdu Easton stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Chengdu Easton's stock expected returns. We can calculate the autocorrelation of Chengdu Easton returns to help us make a trade decision. For example, suppose you find that Chengdu Easton has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Chengdu Easton regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Chengdu Easton stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Chengdu Easton stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Chengdu Easton stock over time.
   Current vs Lagged Prices   
       Timeline  

Chengdu Easton Lagged Returns

When evaluating Chengdu Easton's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Chengdu Easton stock have on its future price. Chengdu Easton autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Chengdu Easton autocorrelation shows the relationship between Chengdu Easton stock current value and its past values and can show if there is a momentum factor associated with investing in Chengdu Easton Biopharmaceuticals.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Chengdu Stock

Chengdu Easton financial ratios help investors to determine whether Chengdu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chengdu with respect to the benefits of owning Chengdu Easton security.